scRNA-seq studies of cells from the primary tumour, residual disease site and the recurrent tumour have shown that MITF-dependent and MITF-independent cells co-exist in the primary tumour, and that MITF-independent cells survive in the residual disease site and contribute to recurrent disease (Travnickova et al., 2019). The gene discussed is MITF; the disease is neoplasm.